Performance analysis of Arrowhead Pharmaceuticals (ARWR)
Annual Return
Over the past 3 years, ARWR has had an average annual return of +25.30%, outperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, ARWR has had an average annual return of -0.47%, underperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, ARWR has had an average annual return of +27.76%, outperforming the benchmark SPY, which returned +15.53% annual.
Since Nov 1, 1999, ARWR has had an average annual return of +0.72%, underperforming the benchmark SPY, which returned +8.59% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +6.67% | +253.11% | -38.56% | -24.55% | -38.82% | -13.59% | +20.96% | +410.74% | +237.52% | +137.36% | -74.79% | -16.72% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -31.97% | +406.83% | -48.88% | -53.20% | +68.87% | -42.40% | -75.66% | -13.69% | +3.06% | -1.62% | +232.36% | +100% |
| 2002 | 2001 | 2000 | 1999 | ||||||||
| -0% | -83.34% | +0% | -33.33% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.42% | -8.74% | -0.90% | +17.20% | +6.03% | -9.10% | +6.67% | ||||||
| 2025 | +5.72% | -4.89% | -32.61% | +9% | +15.71% | -1.67% | +0% | +39.43% | +56.56% | +22.90% | +24.33% | +25.97% | +253.11% |
| 2024 | +4.89% | -0% | -10.90% | -20.90% | +1.45% | +13.26% | +9.88% | -16.55% | -18.73% | -0.72% | +35.38% | -27.78% | -38.56% |
| 2023 | -13.73% | -7.69% | -21.35% | +39.41% | -2.83% | +3.64% | -3.20% | -19.93% | -2.79% | -8.49% | -13.78% | +44.34% | -24.55% |
| 2022 | -20.42% | -16.61% | +4.53% | -10.62% | -18.84% | +5.54% | +20.78% | -6.63% | -16.76% | +5.31% | -7.50% | +25.96% | -38.82% |
| 2021 | +0.57% | +3.23% | -16.76% | +9.73% | -0.23% | +14.08% | -16.34% | -3.12% | -6.99% | +2.22% | +9.76% | -5.35% | -13.59% |
| 2020 | -33.93% | -15.63% | -18.63% | +19.66% | -6.36% | +33.97% | -0.28% | -1.92% | +1.94% | +33.07% | +9.13% | +22.71% | +20.96% |
| 2019 | +13.71% | +38.24% | -5.99% | -2.01% | +31.85% | +11.77% | +9.67% | +17.57% | -17.53% | +42.12% | +82.30% | -13.12% | +410.74% |
| 2018 | +67.89% | +4.92% | +11.19% | -10.96% | +67% | +26.91% | +7.14% | +1.28% | +29.89% | -33.66% | +14.17% | -14.46% | +237.52% |
| 2017 | +25.28% | +16.27% | -18.13% | -16.14% | -7.17% | +12.60% | +8.66% | +59.14% | +54.49% | -15.95% | -1.93% | +3.11% | +137.36% |
Drawdown analysis of Arrowhead Pharmaceuticals (ARWR)
The maximum drawdown for the ARWR was -99.24%, occurring on Dec 16, 2016. This drawdown has not yet recovered.
The current ARWR drawdown is -56.42%.
Since Nov 1, 1999 ARWR has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 3 times
- 20% or more: 3 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.24% | Mar 3, 2000 | 4225 | Dec 16, 2016 | Ongoing | Ongoing | Ongoing |
| -38.83% | Nov 1, 1999 | 53 | Jan 18, 2000 | 1 | Jan 19, 2000 | 54 |
| -31.58% | Feb 4, 2000 | 12 | Feb 23, 2000 | 7 | Mar 3, 2000 | 19 |
| -13.42% | Jan 19, 2000 | 1 | Jan 20, 2000 | 11 | Feb 4, 2000 | 12 |